Director, Clinical Development

Acadia PharmaceuticalsSan Diego, NJ
Hybrid

About The Position

About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we’re here to be their difference. Please note that this position can be based in San Diego, CA, San Francisco, CA OR Princeton, NJ. Acadia's hybrid model requires this role to work in our office three days per week on average. Position Summary Join Acadia as a Director, Clinical Development and play a key role in advancing innovative therapies for neuropsychiatric disorders and rare diseases. In this influential leadership position, you will help shape and execute clinical development strategies, driving programs from early development through critical milestones. Leveraging your deep clinical and scientific expertise, you will collaborate with internal and external stakeholders to support the successful delivery of high-quality clinical programs. This is an exciting opportunity to contribute to groundbreaking research and make a meaningful impact on patients' lives.

Requirements

  • MD or equivalent required; Board Certified/Eligible strongly preferred.
  • An equivalent combination of relevant education and experience may be considered
  • Targeting 3 years of relevant medical/clinical practice, related research, or academic experience within the pharmaceutical industry
  • Ideal candidate will have experience with medical monitoring, including clinical research, creating and implementing development plans and clinical studies.
  • An equivalent combination of relevant education and experience may be considered
  • Established relationships with thought leaders and investigators in depression and other mood disorders
  • Demonstrated leadership to work well within a geographically diverse cross-functional team environment
  • Ability to work within a growing organization within and evolve over time into the world leader in psychiatry and neurology, thereby improving the quality of life of those suffering from CNS disorders
  • Experience interacting with senior leaders, including global regulatory agencies
  • Excellent verbal and written communication skills as well as interpersonal, management, and organizational skills
  • Demonstrated problem solving abilities and conflict resolution skills
  • Ability to engage in an open, constructive and continuous dialogue with the Company’s stakeholders
  • Highly motivated, self-driven and dependable
  • Willing and able to travel both domestically and internationally

Nice To Haves

  • Experience in rare disease and/or neurology strongly preferred

Responsibilities

  • Create and execute global clinical development plans consistent with Company vision and mission
  • Ensure the optimal planning, implementation and interpretation of clinical studies, including synopsis/protocol development, medical monitoring, data analysis and writing of final reports
  • Maintain and build productive relationships with investigators, thought leaders and centers of excellence across the scientific community, as well as with colleagues across the Acadia organization
  • Interact frequently with sites to support study awareness, patient recruitment, and quality of study conduct
  • Communicate appropriate program issues and results to key internal and external stakeholders
  • Support regulatory interactions, including the submission of regulatory documents and presentations
  • Provide clear and insightful clinical and scientific expertise to advance the successful transition of compounds from discovery to full development, and subsequently to life cycle management
  • Review business development opportunities, translating business needs to cost-effective development strategies that provide a competitive advantage and meet regulatory requirements
  • Comply with current local and international regulations, laws, scientific and regulatory guidance, Good Clinical Practices, and Acadia’s policies and procedures
  • Other duties as assigned
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service